Trial intelligence / Profile preview

Pre-operative Olanzapine for Quality of Recovery After Ambulatory Surgery

NCT05676294Phase 2Completed

Sponsor
Yale University
Start
Jun 2023
Primary completion
Dec 2025
Modality
Small Molecules
Countries
1
01

Overview

Phase 2, randomised trial in postoperative nausea and vomiting (PONV) comparing Olanzapine with Placebo (2 arms). Primary endpoint: Quality of Recovery-40 Survey. Started Jun 2023; status: completed.

02

Drugs

olanzapine
03

Conditions

postoperative nausea and vomiting (PONV)

Beyond the preview

Go deeper on NCT05676294.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT05676294.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call